Status:
COMPLETED
Pulmonary Function and Neuromuscular Disease
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Neuromuscular Diseases
Eligibility:
All Genders
6-17 years
Brief Summary
This study aims to describe the evolution of pulmonary function in 3 neuromuscular diseases : Duchenne muscular dystrophy, Werdnig-Hoffinann disease, congenital myopathy, monitored in Besançon univers...
Eligibility Criteria
Inclusion
- Neuromuscular disease
- Followed-up in Besançon University Hospital
- With at least 2 Pulmonary Function Tests previously performed
Exclusion
- Mental deficiency
- Facial expressions disorders
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03445832
Start Date
January 8 2018
End Date
February 10 2018
Last Update
August 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Besançon
Besançon, France